US Patent 7405204 Nucleoside compounds for treating viral infections
Patent 7405204 was granted and assigned to Genelabs Technologies on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+160 characters)
Article
Patent abstract
Disclosed are compounds, compositions and methods for treating viral infections caused by a Flaviviridae family virus, such as hepatitis C virus.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07405204 Nucleoside compounds for treating viral infections US Patent 7405204 Nucleoside compounds for treating viral infections
Infobox
Patent Number
0740520400
Patent Number
740520400
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074052040
Date of Patent
July 29, 2008
0Patent Application Number
114114340
Date Filed
April 25, 2006
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074052040
Date of Patent
July 29, 2008
0Patent Application Number
114114340
Date Filed
April 25, 2006
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07405204 Nucleoside compounds for treating viral infections
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07405204
Date of patent
July 29, 2008
Patent application number
11411434
Date Filed
April 25, 2006
Patent primary examiner
Find more entities like US Patent 7405204 Nucleoside compounds for treating viral infections
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
